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Abstract
Objective: Impulsivity is a ‘‘tendency to act prematurely without foresight.’’ Clinical experience suggests that such impulsive
behavior can impact on the fall risk in Parkinson’s disease (PD), but this has never been tested. We investigated whether trait
impulsivity is related to fall risk in a large cohort of PD patients. We also investigated whether trait impulsivity affects the fall
risk differently for patients with more or less postural instability and gait disability (PIGD).
Methods: 388 patients with PD (H&Y#3) completed the Barratt Impulsiveness Scale (BIS-11, higher scores indicating greater
impulsivity) to assess trait impulsivity, including three subscales: motor impulsivity (e.g. ‘‘I do things without thinking’’),
attentional impulsivity (e.g. ‘‘I concentrate easily’’) and non-planning (e.g. ‘‘I plan tasks carefully’’). Falls were registered
prospectively for 6 months. Patients classified as non-fallers (0 falls, n = 237) were compared to recurrent PD fallers (.1 fall,
n = 78).
Results: Total impulsivity scores were higher for recurrent fallers (59.5) compared to non-fallers (56.8; p = .012). This effect
was predominantly driven by higher scores on the subscale for attentional impulsivity (p = .003). The difference in
attentional impulsivity was independent of gender, disease severity, dopaminergic medication, and cognitive function.
Motor and non-planning impulsivity did not differ between recurrent fallers and non-fallers. There was no evidence that
impulsivity modulated the association between PIGD and fall risk.
Discussion: This is the first evidence that impulsivity, in particular in the attentional domain, is related to fall risk in PD.
Citation: Smulders K, Esselink RA, Cools R, Bloem BR (2014) Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s Disease. PLoS ONE 9(3): e91190.
doi:10.1371/journal.pone.0091190
Editor: Oscar Arias-Carrion, Hospital General Dr. Manuel Gea Gonza´lez, Mexico
Received July 1, 2013; Accepted February 11, 2014; Published March 7, 2014
Copyright:  2014 Smulders et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by ZonMw, the Netherlands Organization for Health Research and Development (75020012 to BRB), and the Michael J. Fox
Foundation for Parkinson’s Research (to BRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: katrijn.smulders@gmail.com
Introduction
Falls in Parkinson’s disease (PD) are common and incapacitating
[1]. Considering the hallmark motor symptoms of PD, the high fall
rate is understandable. However, not all patients with postural
instability or gait disability fall, perhaps because these patients
compensate by moving more cautiously. In contrast, frequent
fallers might miss such adaptive behavior, perhaps due to lack of
insight or impulsivity [2]. Indeed, Ahlskog stated that ‘‘…some of
the worst fallers are those who impulsively jump from their chair
or turn without thinking’’ [3]. Quinn coined the term ‘‘motor
recklessness’’ to describe such behavior, which is common in
patients with progressive supranuclear palsy [4]. There is as yet,
however, no quantitative proof for this clinical observation.
Impulsivity is a complex concept, including ‘‘actions that are
poorly conceived, prematurely expressed, unduly risky, or
inappropriate to the situation and that often result in undesirable
outcomes’’ [5]. Our primary aim was to investigate whether trait
impulsivity is associated with fall risk in PD patients. To this end,
we assessed trait impulsivity using the Barratt Impulsiveness Scale
11 (BIS-11) to assess the personality construct of impulsivity. The
BIS-11 distinguishes motor impulsivity (‘‘acting without thinking’’)
[6], attentional impulsivity (a lack of ‘‘focusing on the task at
hand’’ and ‘‘thought insertions and racing thoughts’’) [7], and
non-planning impulsivity (a lack of ‘‘futuring or forethought’’)
[6,7]. Fall incidents were prospectively monitored for a period of
six months in a large cohort of PD patients. As a second aim, we
investigated whether trait impulsivity modulates the association
between postural instability and gait disability and fall risk.
Methods
Ethics Statement
This study was approved by the regional medical ethics
committee (CMO region Arnhem-Nijmegen). Written informed
consent was obtained from all participants before the first
assessment.
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Participants
The included patients are a subset of the 586 PD patients who
participated in the ParkFit study, a multicentre, randomized
clinical trial that evaluated the effectiveness of a behavioral
program to promote physical activity [8]. Eligibility criteria in the
ParkFit study were PD according to the UK Brain Bank criteria
[9], Hoehn and Yahr (H&Y) #3 [10], age between 40 and 75
years, and a sedentary lifestyle. Exclusion criteria were: unclear
diagnosis (no gratifying, sustained response to dopaminergic
therapy), Mini-Mental State Examination (MMSE) ,24 [11],
unable to complete Dutch questionnaires, severe co-morbidity,
daily institutionalized care, and deep brain surgery.
After exclusion of participants who had no (n= 124) or
incomplete BIS-11 questionnaires (n = 16), or incomplete fall
records (n = 58), 388 participants were included. There were no
significant differences between included and excluded patients
with regard to demographic (age, gender, educational level) and
disease characteristics (H&Y stage, MMSE). Because recurrent
falls are generally viewed as indicative of pathology, whereas single
falls can be regarded as occasional falls with uncertain clinical
relevance [12–14], we excluded all patients with a single fall over 6
months (n = 73) for the primary analysis (see Falls). This resulted in
a sample of 315 patients (66% men, 6568 years). Mean Unified
Parkinson’s Disease Rating Scale-III (UPDRS-III) was 33610,
76% were in H&Y stage 2 (H&Y 1:2; H&Y 1.5:3%; H&Y
2.5:16%; H&Y 3:5%), and mean MMSE score was 2862
(Table 1).
Items 27–30 of the UPDRS-III (arising from chair, posture,
gait, postural stability) were summed to calculate PIGD scores of
the participants. Total levodopa dose equivalent (LED) was
calculated, pooling different drugs according to the following
formula: regular levodopa dose61+ slow release levodopa60.7+
bromocriptine610+ apomorphine610+ ropinirole620+ pergo-
lide6100+ pramipexole6100+ [regular levodopa dose+(slow
release levodopa60.7)] 60.2 if taking entacapone [15]. LED
values for dopamine agonists (LED-agonists) were calculated using
the same formula excluding the levodopa factors.
The level of physical activity level was assessed with the LASA
physical activity questionnaire (LAPAQ), a validated seven day
recall of physical activities [16].
Cognitive Assessment
All participants completed a cognitive test battery to assess
attentional set switching (CANTAB intra-extra dimensional set
shift (IDED)), spatial working memory (CANTAB SWM test), and
verbal fluency (letter fluency) [17,18].
Trait Impulsivity
The Dutch version of the Barratt Impulsiveness Scale 11 is a
self-report instrument to assess the personality construct of
impulsivity [7,19]. The questionnaire consists of 30 items that
are scored on a four point scale (1–4) and that taps into three sub-
traits: motor impulsivity (e.g. ‘‘I do things without thinking’’),
attentional impulsivity (e.g. ‘‘I concentrate easily), and non-planning
impulsivity (e.g. ‘‘I plan tasks carefully’’). Total impulsivity is
calculated as the sum of all items. Higher scores on the BIS-11
indicate greater impulsivity. Previous studies have shown adequate
internal consistency with Cronbach’s a of 0.81 in a study using the
Dutch BIS-11 [20]. Cronbach’s a of the total BIS score in the
present study was 0.75. Cronbach’s alpha for attentional BIS was
0.67, for non-planning BIS 0.63 and for motor BIS 0.38.
Falls
Falls were registered monthly using an automated system to
monitor falls by telephone (Falls Telephone, ASK Community
Systems). The Falls Telephone called participants every month
and asked them how many times they had fallen in the previous
month. The Falls Telephone is a reliable instrument to monitor
Table 1. Demographic and clinical measures for fall groups.
Non-fallers Recurrent fallers P value
N 237 78
Age 6568 6568 .715
Gender (% M) 69% 56% .046
Hoehn & Yahr (%)
1 1% 3%
1.5 3% 1%
2 80% 63% .001
2.5 14% 20%
3 2% 13%
UPDRS-III 32610 37611 ,.001
PIGD 2.661.6 3.561.7 ,.001
MMSE 2862 2862 .097
Falls 0 567 ,.001
LED total 4326399 6346478 ,.001
% using DA agonists 51% 65% .027
LED-agonists 1236226 1646163 .137
Physical activity level (hours/week) 15.6610.7 17.3610.7 .227
P values of independent t-tests and chi-square are presented to compare fall groups.
UPDRS-III: Unified Parkinson’s Disease Rating Scale motor examination; PIGD: Postural Instability and Gait Disability; MMSE: Mini-Mental State Examination; LED:
Levodopa Equivalent Dose. DA: dopamine.
doi:10.1371/journal.pone.0091190.t001
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falls in PD (sensitivity: 100%, specificity: 78%) [21]. All fall entries
were verified by a personal telephone call of trained research
assistants to further increase specificity. A fall was defined as ‘‘an
unexpected event in which the participant comes to rest on the
ground, floor, or lower level’’ [22]. To illustrate, falling back in a
chair when trying to stand up from a chair was not characterized
as a fall, whereas standing upright in front of a chair, losing
balance and falling into a chair, was counted as a fall. Participants
were classified as non-faller (0 falls over 6 months), single faller (1
fall over 6 months) and recurrent faller (.1 fall over 6 months).
These groups differed significantly with regard to UPDRS-III (p,
.001), H&Y (p= .002) and PIGD (p,.001). Compared to the non-
fallers, single fallers had significantly higher UPDRS-III (p= .032)
and PIGD scores (p= .041), but did not have different H&Y stages
(p= .809). Compared to the recurrent fallers, single fallers had
lower H&Y (p= .002) and PIGD scores (p= .0049), but these
groups did not differ with regard to UPDRS-III scores (p= .137).
Statistical Analysis
Statistical tests on demographic, clinical, cognitive and impul-
sivity outcomes were carried out comparing non-fallers with
recurrent fallers. Independent samples t-tests were used for
continuous variables, and Chi-square tests for categorical
variables. Effect size was calculated using Cohen’s d for the
difference between non-fallers and recurrent fallers in case of
significant differences on impulsivity measures. In an additional
analysis, we included the single fallers in the group of non-fallers
(non-recurrent fallers, #1 falls) and compared impulsivity scores of
this group with the group of recurrent fallers (.1 falls).
To account for the possible contribution of gender, disease
severity (H&Y and PIGD), and dopaminergic medication (LED
total and LED-agonists) on impulsivity or fall risk, we constructed
four multivariate logistic regression models (forced entry) with fall
group (non-fallers vs. recurrent fallers) as the dependent variable.
In model 1, total impulsivity and gender were included as
independent factors. In model 2 total impulsivity, H&Y and PIGD
scores were included as independent factors. In model 3 total
impulsivity, LED total and LED-agonists were the independent
factors. Finally, we investigated whether fall risk was predicted by
impulsivity independent of cognitive function. In this fourth model
we added the cognitive tests that were significantly different
between fall groups and MMSE score as independent factors
together with total impulsivity. These analyses were repeated
replacing total impulsivity with subscales that were significantly
different between non-fallers and recurrent fallers.
To assess whether impulsivity modulated the effect of PIGD on
fall risk, a logistic regression analysis (forced entry method) was
applied with fall group as dependent variable, and the interaction
term total impulsivity x PIGD, total impulsivity and PIGD as
independent variables. The independent factors were centered to
facilitate the interpretation of the coefficients. This analysis was
repeated with subscales that were significantly different between
non-fallers and recurrent fallers instead of total impulsivity.
Significance was accepted at p,.05 for all analyses.
Results
Demographic and Clinical Differences Between Fall
Groups (Table 1)
Seventy-eight (25%) participants reported more than one fall in
the period of six months. Non-fallers and recurrent fallers were
comparable with regard to age and MMSE scores (all p’s..1).
Women were more likely to report recurrent falls (p= .046).
Compared to non-fallers, recurrent fallers had higher H&Y stages
(p= .001) and higher UPDRS-III and PIGD scores (p’s,.001).
Regarding dopaminergic medication, recurrent fallers had higher
LED values than non-fallers (p’s,.001). Although the percentage
of recurrent fallers using dopamine agonists was higher than that
of non-fallers (p= .027), the groups did not differ in LED-agonists
(p= .137). Recurrent fallers and non-fallers had comparable levels
of physical activity (p= .227).
Impulsivity and Fall Risk
Patients with PD who experienced multiple falls scored 2.7
points higher on the total BIS-11 than non- fallers (t1,313 =22.54,
p= .012, Table 2). Of the subscales, only attentional impulsivity
was different between recurrent fallers and non-fallers, with 1.2
higher impulsivity scores for the fallers (t1,313 =22.83, p= .005).
Effect sizes were small to medium; Cohen’s d was 0.33 for total
impulsivity and 0.37 for attentional impulsivity. Motor impulsivity
(t1,313 =21.22, p= .225) and non-planning (t1,313 =21.66,
p= .098) did not differ between fall groups.
In an additional analysis we compared impulsivity scores of
non-recurrent fallers (consisting of the non-fallers and single fallers)
with those of recurrent fallers. The results of this analysis were
similar to the primary analysis: Recurrent fallers had higher total
(t1,386 =22.33, p= .020) and attentional impulsivity scores
(t1,386 =22.42, p= .016) than non-recurrent fallers. The groups
did not differ on motor (t1,386 =21.28, p= .203) and non-planning
impulsivity (t1,386 =21.57, p= .116).
Controlling Gender, Disease Severity, and Dopaminergic
Medication
We constructed multivariate regression models to assess whether
impulsivity contributed to recurrent fall risk independently of
gender, disease severity, and dopaminergic medication (Table 3
and 4). These analyses showed that total impulsivity was an
independent predictor of fall risk when gender and disease severity
were controlled, with an odds ratio of 1.04 (95% CI: 1.03–1.08
controlling gender; 95% CI: 1.03–1.07 controlling disease
severity). In contrast, total impulsivity was not an independent
predictor for fall risk when dopaminergic medication was
controlled.
Attentional impulsivity was a consistent, independent contrib-
utor to fall risk in all regression models with odd’s ratios between
1.09–1.11 (95% CI: 1.03–1.19 controlling gender or disease
severity; 95% CI: 1.00–1.18 controlling medication). Other
significant contributors to fall risk were PIGD (in model with
total BIS: OR: 1.31, 95% CI: 1.08–1.60; in model with attentional
BIS: OR: 1.31, 95% CI: 1.07–1.59) and LED total (in model with
total BIS: OR: 3.10, 95% CI: 1.45–6.64; in model with attentional
BIS: OR: 3.06, 95% CI: 1.42–6.57).
Cognitive Function
There were no significant differences between recurrent and
non-fallers on the cognitive tests assessing attentional set shifting
and spatial working memory (p’s..08; Table 5). Recurrent fallers
scored significantly lower on verbal fluency compared with non-
fallers (p= .042). However, logistic regression demonstrated that
total BIS (OR: 1.04, 95% CI: 1.01–1.08) and attentional BIS (OR:
1.11, 95% CI: 1.03–1.20) remained independent significant
predictors for fall risk when controlled for letter fluency
performance and MMSE score (Table 3 and 4).
Impulsivity, PIGD, and Fall Risk
To assess whether impulsivity has a larger effect on fall risk for
patients with more gait and balance problems, a logistic regression
Impulsivity and Falls in PD
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model with independent factors total impulsivity x PIGD, total
impulsivity and PIGD, and fall group as dependent factor was
constructed. Total impulsivity x PIGD was not an independent
predictor of fall group in this model (p,.239). Additionally, we
tested the interaction between subscale attentional impulsivity and
PIGD as a predictor for fall risk in a similar model. This
interaction term was also not a significant predictor of fall risk
when the main effects were controlled (p= .348).
Discussion
The present data suggest that trait impulsivity is associated with
the risk of falls for patients with PD. Patients who sustained
multiple falls within 6 months reported higher impulsivity than
non-fallers. In particular, fallers scored higher on attentional
impulsivity, although the effect size was small to medium. This
difference was independent of gender, disease severity, amount of
dopaminergic medication use, and cognitive function. We did not
find evidence that impulsivity influenced fall risk differently in
patients with high or low PIGD scores.
Attentional impulsivity reflects a tendency to be more sensitive
to distraction [7,19]. If a patient cannot adequately devote
attention to gait and postural stability, and is susceptible to
distraction, then this likely challenges stability. Hence, an
alternative account for our findings is that impaired attention
underlies differences between fall groups rather than impulsivity.
Indeed, difficulty with sustained attention has been associated with
fall risk in PD before [23], and in the current study recurrent
fallers scored lower on a test of verbal fluency than non-fallers. To
rule out the possibility that attentional deficits could explain our
findings, we controlled for differences on this cognitive test and
found that the association between impulsivity and fall risk was
independent of attentional functions. This finding is in line with a
previous study of our group showing that attentional demands
operationalized in a dual-task paradigm could not explain fall risk
in PD [24]. Moreover, in a study of healthy young subjects, the
BIS-11 was found to correlate with performance on a neuropsy-
chological test assessing impulsivity, but not with a measure of
sustained attention [25]. Hence, our findings suggest that
impulsive behavior of the recurrent fallers represents a different
construct than attentional deficits.
Based on prior work [26,27], motor impulsivity was the most
likely candidate to correlate with falls. This aspect of impulsivity
reflects the inability to control prepotent, impulsive actions [28].
The only other study evaluating impulsivity and fall risk reported
that stroke patients with a history of falls performed more poorly
on a task assessing motor impulsivity (bilateral scanning task) [26].
The idea that falling in PD might be related to motor impulsivity
came from another study demonstrating that PD patients with
predominantly postural instability and gait disability tended to
make more impulsive errors in a computerized lab tests (Simon
task) compared with tremor-dominant patients [27]. The authors
suggested that motor impulsivity in combination with PIGD
symptoms makes PD patients extra vulnerable for falls. Our results
generally concur with this suggestion. However, impulsivity,
whether self-reported or measured with computerized tests in
the lab, is well known to be a multifactorial phenomenon [29,30].
Here we extend this prior work by showing that fall risk is
particularly associated with self-reported attentional rather than
motor impulsivity. Whether this effect of self-reported attentional
impulsivity extends to attentional impulsivity as measured with
laboratory computer tests, e.g. in terms of premature responding
on a 5 choice task, remains to be determined.
We had expected that impulsive behavior would mainly be risky
for patients with greater postural instability and gait disability.
However, our findings were not consistent with this hypothesis.
We observed that total impulsivity increased fall risk for patients
with both higher and lower PIGD scores, evidenced by a non-
significant contribution of the impulsivity x PIGD interaction term
to fall risk. To illustrate the impact of impulsivity, patients with
high impulsivity scores (total or attentional) were 1.7 times as likely
to fall compared with patients with low impulsivity scores (OR for
an interquartile range increase). These findings suggest that
impulsive tendencies need consideration in the clinic, even in
patients who present with minor axial impairments.
We considered the role of dopaminergic medication, because
dopamine replacement therapy, and particularly dopamine
agonist dosage, is associated with impulse control disorders
(ICD) in PD [31–33]. Moreover, the fallers in our study were on
a higher dose of dopamine, presumably because of their greater
disease severity. Theoretically, this could mean that higher disease
severity caused falls and, in parallel, called for more dopaminergic
medication, thereby increasing impulsivity. To falsify this expla-
nation, we controlled for dosage of dopaminergic medication,
dosage of dopamine agonists and disease severity in our analysis,
and this did not change the finding that attentional impulsivity was
higher in recurrent fallers compared to non-fallers. However, the
addition of total LED values resulted in non-significant associa-
tions between total impulsivity and fall risk. Hence, the role of
dopamine in impulsive behavior and fall risk needs to be further
explored.
The patients of our cohort had to have a sedentary lifestyle in
order to be eligible for the study and were in the early to moderate
stages of PD. This selection limits generalization to the general PD
population. Nevertheless, falls were common in this cohort. This
stresses the need to improve identification of patients who are at
risk for falls, preferably before the first fall. A second limitation is
the use of the BIS questionnaire. The BIS-11 has not yet been
validated in a cohort of PD patients. Moreover, we found that the
motor BIS had low internal consistency. Validation of the total
BIS and its subscales in an independent cohort, representative of
Table 2. Self-reported impulsivity scores (BIS-11) for fall groups.
Non-fallers Recurrent fallers T P value Cohen’s d
Total impulsivity 56.868.3 59.568.0 22.54 .01 0.33
Motor impulsivity 18.162.8 18.562.6 21.22 .23 2
Attentional impulsivity 14.563.4 15.763.7 22.83 .005 0.37
Non-planning 24.364.7 25.364.6 21.66 .10 2
P values are presented for comparisons between fall groups using the independent samples t-test.
Cohen’s d indicates effect size (0.2: small effect; 0.5: medium effect; 0.8: large effect).
doi:10.1371/journal.pone.0091190.t002
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the general PD population is therefore warranted. Finally, in a
recent study it was found that PD patients with ICD’s score higher
on attentional BIS, but not on total BIS, than the ICD negative
patients [34]. Extending this finding to our study would suggest
that our recurrent fallers might be more at risk for ICD’s. In that
regard, it would have been interesting to document ICD’s in our
cohort as another dimension of impulsivity. However, the absence
of information on ICD status in our cohort does not diminish the
validity of our interpretations with regard to the relation between
trait impulsivity and falls.
The present study provides the first evidence that trait
impulsivity is associated with fall risk in PD. However, impulsivity
is a complex multifactorial phenomenon [30]. Future research is
needed to further explore different aspects of impulsive behavior in
relation to fall risk (see [29] for a theoretical framework).
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